Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA
Filed in archive News , Treatment by Gloria Gamat on April 18, 2007

Tablets has recently been granted final approval by the US FDA. Both oral blood glucose lowering drugs, glipizide and metformin are used for the treatment of type 2 diabetes when diet alone is not sufficient, but with different mechanisms of action: glipizide by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently while metformin hydrochloride, by decreasing sugar production and absorption and helping your body respond better to its own insulin.
Glipizide's popular brand is Glucotrol® by Pfizer while metformin hydrochloride is known as the brand Glucophage®, a product of Bristol-Myers Squibb.
Additionally, these two blood glucose-lowering ingredients are found in one product: Bristol-Myers Squibb's Metaglip™ Tablets.
Thanks to Mylan Pharmaceuticals, Metaglip™ now has a USFDA-approved generic counterpart.
Source: Mylan Laboratories, Inc.
Permalink: Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA
Tags:
generic
drugs
metformin
glipizide
type
2
diabetes
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/64265

Mr Wong

